Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Non-cash Items (2020 - 2025)

Bolt Biotherapeutics' Non-cash Items history spans 5 years, with the latest figure at $2.8 million for Q4 2024.

  • For Q4 2024, Non-cash Items rose 23233.33% year-over-year to $2.8 million; the TTM value through Dec 2024 reached $2.8 million, up 23233.33%, while the annual FY2024 figure was $2.8 million, 23233.33% up from the prior year.
  • Non-cash Items for Q4 2024 was $2.8 million at Bolt Biotherapeutics, up from $12000.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $14.6 million in Q4 2022 and bottomed at $12000.0 in Q4 2023.
  • The 5-year median for Non-cash Items is $4.7 million (2020), against an average of $5.6 million.
  • The largest annual shift saw Non-cash Items tumbled 99.92% in 2023 before it surged 23233.33% in 2024.
  • A 5-year view of Non-cash Items shows it stood at $4.7 million in 2020, then rose by 28.68% to $6.1 million in 2021, then skyrocketed by 140.33% to $14.6 million in 2022, then crashed by 99.92% to $12000.0 in 2023, then soared by 23233.33% to $2.8 million in 2024.
  • Per Business Quant, the three most recent readings for BOLT's Non-cash Items are $2.8 million (Q4 2024), $12000.0 (Q4 2023), and $14.6 million (Q4 2022).